hu14.18 (K322A) is a humanized monoclonal antibody targeting disialoganglioside GD2, comprised of a fully human amino acid sequence of immunoglobulin G1 heavy chain and kappa light chain. This antibody exhibits antibody-dependent cellular cytotoxicity (ADCC) and is utilized in studying high-risk neuroblastoma.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted